The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Coleman Kirk Allen since 2019.
This trader's CIK number is 1790624.
At the time of last reporting, Coleman Kirk Allen was the Chief Financial Officer of Tff Pharmaceuticals, Inc.. (stock ticker symbol TFFP).
Also see all insider trading activities at Tff Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | TFFP | 32,000 | $14,456 | 0 | $0 | 0 | $0 |
| 2022 | TFFP | 1,675 | $7,552 | 0 | $0 | 0 | $0 |
| 2021 | TFFP | 1,000 | $7,300 | 15,000 | $256,850 | 15,000 | $37,500 |
| 2020 | TFFP | 0 | $0 | 25,000 | $379,155 | 25,000 | $62,500 |
| 2019 | TFFP | 1,000 | $5,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-15 | TFFP | Buy | 20,000 | .25 | 5,000 |
| 2023-03-10 | TFFP | Buy | 12,000 | .79 | 9,456 |
| 2022-05-16 | TFFP | Buy | 1,250 | 4.40 | 5,500 |
| 2022-05-17 | TFFP | Buy | 425 | 4.83 | 2,052 |
| 2021-09-16 | TFFP | Buy | 1,000 | 7.30 | 7,300 |
| 2021-03-15 | TFFP | Option Ex | 5,000 | 2.50 | 12,500 |
| 2021-03-15 | TFFP | Sale | 5,000 | 17.05 | 85,250 |
| 2021-02-16 | TFFP | Sale | 5,000 | 16.82 | 84,100 |
| 2021-02-16 | TFFP | Option Ex | 5,000 | 2.50 | 12,500 |
| 2021-01-15 | TFFP | Option Ex | 5,000 | 2.50 | 12,500 |
| 2021-01-15 | TFFP | Sale | 5,000 | 17.50 | 87,500 |
| 2020-12-23 | TFFP | Option Ex | 10,000 | 2.50 | 25,000 |
| 2020-12-23 | TFFP | Sale | 10,000 | 15.24 | 152,400 |
| 2020-11-10 | TFFP | Sale | 15,000 | 15.12 | 226,755 |
| 2020-11-10 | TFFP | Option Ex | 15,000 | 2.50 | 37,500 |
| 2019-10-25 | TFFP | Buy | 1,000 | 5.00 | 5,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coleman Kirk Allen (Chief Financial Officer of Tff Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.